Clinical studies suggest these vaccines can generate immunological memory, allowing lymphocytes to respond to tumor recurrence.
A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA cancer vaccine platform. The study introduces an immune cell homing ...
The $48 million award, granted through the Advanced Research Projects Agency for Health, will help Kernal take its in vivo mRNA-encoded CAR T therapy forward.
Money Talks News on MSN
Universal Cancer Vaccine Could Work Against All Cancer Types: Human Trials Begin
Breakthrough universal cancer vaccine using mRNA technology enters human trials, potentially working against all cancer types without personalization delays.
The Armenian immigrant and Flagship Pioneering visionary has spent decades turning scientific impossibilities into realities—and even though he sees the scary part in everything, he also sees a bright ...
Why are we so ill-prepared for the common cold? It’s not because the common cold has been neglected by scientists or vaccine manufacturers, but because it’s actually a really wily opponent. If ...
MedPage Today on MSN
CDC Ends Universal Recommendation for COVID Vaccine
CDC's endorsement makes ACIP's guidance into official federal policy, triggering no-cost insurance coverage for most private and public insurance plans as well as access via the Vaccines for Children ...
There’s a “paradox” at work in global health, as the philanthropist Bill Gates wrote last week. Even as funding for global health is declining, the science that supports those efforts is accelerating.
The vaccine advisory panel for the Centers for Disease Control and Prevention (CDC) is planning to look into the timing of other childhood vaccine schedules, soon after it voted to delay the measles, ...
A substantial body of evidence supports the safety of the COVID-19 vaccines during pregnancy, contrary to the suggestions of some members of the Centers for Disease Control and Prevention’s vaccine ...
The CDC recently approved new recommendations for the COVID vaccine, which differ from previous years' guidance.
Angelica Meyer highlights downstream bioprocessing challenges, emphasizing quality, innovation, and advancing transformative therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results